Small Molecules

18 Jan 2007 Barrier Therapeutics Announces Positive Phase 2a Data for Oral Hivenyl(TM) in the Treatment of Itch in Atopic Dermatitis
18 Jan 2007 Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate From Bayer Schering Pharma
18 Jan 2007 Cipher Pharmaceuticals's Response To Approvable Letter For CIP-ISOTRETINOIN Accepted For Review By FDA
18 Jan 2007 Neoprobe Receives Clearance For Additional Lymphoseek Trials
18 Jan 2007 Metabolex Shows MBX-102/JNJ-39659100 Reduces Inflammation in Preclinical Models of Diabetes
18 Jan 2007 Elixir Pharmaceuticals Presents Ghrelin Antagonist Program at European Conference on Aging
17 Jan 2007 Merck Serono Announces Positive Results From Phase III Diet Study Of Phenoptin For Phenylketonuria
17 Jan 2007 Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
17 Jan 2007 Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome
17 Jan 2007 ArQule Provides Clinical Trial Update
17 Jan 2007 Hana Biosciences Receives Orphan Drug Designation for Marqibo (Vincristine Sulfate Liposomes Injection) for the Treatment of Acute Lymphoblastic Leukemia
17 Jan 2007 DOV Pharmaceutical Announces Exclusive Agreement for the Development and Commercialization of Bicifadine
17 Jan 2007 Marketing License Granted in The Netherlands for Adult Patients with Depression
17 Jan 2007 Vicus Therapeutics Announces FDA Approval of Phase 2 Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer
17 Jan 2007 Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103
17 Jan 2007 FDA Approves LIALDAâ„¢ (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
17 Jan 2007 Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
16 Jan 2007 Merck Serono Completes Patient Enrollment In Clarity Phase III Pivotal Clinical Trial Of Oral Cladribine
16 Jan 2007 Results of Sativex(R) Phase III Neuropathic Pain Trials Demonstrate Benefits for High Need Treatment-Resistant Patients
16 Jan 2007 Arrow Therapeutics selects a further Hepatitis C clinical candidate
16 Jan 2007 Isotechnika's partner, Lux Biosciences, receives orphan drug designation for ophthalmic indications of ISA247
15 Jan 2007 Can-Fite Progresses Through Clinical Trials: Completed Enrolment of 250 Patients in Phase IIb Rheumatoid Arthritis (RA) Trial
13 Jan 2007 Bioxell Acquires Novel Compound from Roche
13 Jan 2007 Cipralex(R) approved for the treatment of obsessive compulsive disorder (OCD)
13 Jan 2007 Recent Study Shows Favorable Results of Solage(R) (mequinol 2%, tretinoin 0.01%) Topical Solution for the Treatment of Solar Lentigines in Dark Skin Types

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top